High Vista Strategies LLC Atreca, Inc. Transaction History

High Vista Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.82 - $13.8 $268,233 - $473,353	-34,301 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.0 - $19.34 $45,201 - $67,245	3,477 Added 11.28%	34,301 $526,000
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $401,636 - $526,782	30,824 New	30,824 $498,000
Q3 2020 Nov 16, 2020	SELL	$12.67 - $23.19 $194,231 - $355,502	-15,330 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.52 - $23.45 $191,931 - $359,488	15,330 New	15,330 $326,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.